Please use this identifier to cite or link to this item: https://rima.ufrrj.br/jspui/handle/20.500.14407/14171
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSilva, Bruno Ricardo Soares Alberigi da
dc.date.accessioned2023-12-22T02:57:03Z-
dc.date.available2023-12-22T02:57:03Z-
dc.date.issued2016-02-29
dc.identifier.citationSilva, Bruno Ricardo Soares Alberigi da. Diagnóstico da cardiomiopatia hipertrófica em gatos (Felis catus Linnaeus,1758) pelo curto doméstico. 2016. [102 f.]. Dissertação (Prgrama de Pós-Graduação em Medicina Veterinária (Patologia e Ciências e Clínicas) - Universidade Federal Rural do Rio de Janeiro, Seropédica-RJ.por
dc.identifier.urihttps://rima.ufrrj.br/jspui/handle/20.500.14407/14171-
dc.description.abstractA cardiomiopatia hipertrófica, é a cardiopatia mais comum nos gatos, sendo caracterizada pela hipertrofia concêntrica do ventrículo esquerdo. É uma doença de origem genética, autossômica dominante de penetrância incompleta, que predispõem os animais a alterações secundárias do sistema cardiovascular como arritmias e tromboembolismo, causas possíveis de morte súbita destes animais. Apesar de sua ocorrência estar tradicionalmente relacionada às raças Maine Coon, Ragdoll, Sphynx e Persa, a cardiomiopatia hipertrófica pode acometer qualquer outra raça e até mesmo gatos sem raça definida. O objetivo do presente estudo foi realizar o diagnóstico da cardiomiopatia hipertrófica em uma população de gatos pelo curto doméstico, e relacionar os achados clínicos e de imagem com diagnóstico precoce da doença. Foram submetidos ao exame ecodopplercardiográfico 135 gatos pelo curto doméstico, entre machos e fêmeas de diferentes idades, sem histórico prévio de suspeita de cardiopatia, para identificação da hipertrofia ventricular concêntrica do ventrículo esquerdo. Foram considerados animais portadores de hipertrofia aqueles que apresentaram medidas de septo interventricular e/ou parede livre do ventrículo esquerdo, ambos na diástole, maiores que 5 mm de espessura. Os animais identificados com hipertrofia ventricular concêntrica, foram submetidos, além do exame clínico, à exames laboratoriais de ureia, creatinina, sódio, potássio, cálcio iônico, fósforo, T4total e urinálise, e exames de imagem como ultrassonografia, para diagnóstico diferencial de doenças que possam causar hipertrofia concêntrica, como hipertensão arterial, doença renal crônica, hiperaldosteronismo e hipertireoidismo. Foram diagnosticados 10 gatos portadores de hipertrofia ventricular concêntrica, destes cinco foram classificados como portadores de hipertrofia ventricular concêntrica secundária a outras doenças, sendo o hipertireoidismo a principal causa (4/5) e cinco caracterizados como portadores de cardiomiopatia hipertrófica. Com base nos resultados pôde-se concluir que a cardiomiopatia hipertrófica: 1) apresentou prevalência de 3,7% na população de gatos pelo curto doméstico da cidade do Rio de Janeiro; 2) cursa com evolução silenciosa quanto aos aspectos clínicos; 3) apresentou diversidade fenotípica quanto ao local de acometimento no ventrículo esquerdo; e 4) além da espessura de septo e parede livre na diástole, outras medidas ecodopplercardiográficas limítrofes sinalizam a necessidade de acompanhamento do paciente, para diagnóstico precoce de futuras complicaçõespor
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESpor
dc.formatapplication/pdf*
dc.languageporpor
dc.publisherUniversidade Federal Rural do Rio de Janeiropor
dc.rightsAcesso Abertopor
dc.subjectHeart diseaseeng
dc.subjectEchocardiographyeng
dc.subjectHypertrophyeng
dc.subjectCardiopatia..por
dc.subjectEcodopplercariogramapor
dc.subjectHipertrofiapor
dc.titleDiagnóstico da cardiomiopatia hipertrófica em gatos (Felis catus Linnaeus,1758) pelo curto domésticopor
dc.title.alternativeDiagnosis of hypertrophic cardiomyopathy in cats (Felis catus Linnaeus, 1758) by domestic shorteng
dc.typeDissertaçãopor
dc.description.abstractOtherHypertrophic cardiomyopathy is the most common heart disease in cats and it is characterized by concentric left ventricular hypertrophy. It is a genetic disease, autosomal dominant with incomplete penetrance, which predispose animals to minor changes in the cardiovascular system as arrhythmias and thromboembolism, these being possible causes of sudden death of these animals. Although traditionally linked to the involvement of breeds of cats like Maine Coon, Ragdoll, Sphynx and Persian, hypertrophic cardiomyopathy can affect any breed and even mixed breed cats. The aim of this study was the diagnosis of hypertrophic cardiomyopathy in a population of domestic short hair cats, and relate with the clinical and imaging findings with early diagnosis. Were evaluated 135 domestic short hair cats by Doppler echocardiography, between males and females of different ages, no previous history of suspected heart disease, to identify the concentric ventricular hypertrophy of the left ventricle. Were recognized cats with hypertrophy those, which interventricular septum and the free wall of the left ventricle measures during diastole, animal that presented 5 mm thickness on this measures. Animals identified with concentric ventricular hypertrophy were subjected to laboratory tests of urea, creatinine, sodium, potassium, ionized calcium, phosphorus, T4total, urinalysis, and imaging tests like ultrasound for differential diagnosis of diseases that can cause concentric hypertrophy, such as hypertension, chronic kidney disease, hyperaldosteronism and hyperthyroidism. Were diagnosed 10 cats with concentric ventricular hypertrophy, these five were classified as having concentric secondary ventricular hypertrophy to other diseases and five characterized as having hypertrophic cardiomyopathy. Among the results was noted that hypertrophic cardiomyopathy presents: 1) prevalence of 3.7%; 2) silent evolution for clinical aspects; 3) even with borderline measures, has changes that need monitoring for early diagnosis of complications; 4) a phenotypic diversity as the site of involvementeng
dc.contributor.advisor1Paiva, Jonimar Pereira
dc.contributor.advisor1ID8843371703por
dc.contributor.advisor1Latteshttp://lattes.cnpq.br/0555358847663175por
dc.contributor.referee1Almeida, Flavya Mendes de
dc.contributor.referee2Souza, Heloísa Justen Moreira de
dc.creator.ID115.152.237-60por
dc.creator.Latteshttp://lattes.cnpq.br/5366748874483915por
dc.publisher.countryBrasilpor
dc.publisher.departmentInstituto de Veterináriapor
dc.publisher.initialsUFRRJpor
dc.publisher.programPrograma de Pós-Graduação em Medicina Veterinária (Patologia e Ciências Clínicas)por
dc.relation.references7. REFERÊNCIAS BIBLIOGRÁFICAS ABBOTT, J. A. Feline hypertrophic cardiomyopathy: An update. Veterinary Clinics of North America - Small Animal Practice, v. 40, n. 4, p. 685–700, 2010. ASH, R.A., HARVEY, A.M.; TASKER, S.Primary hyperaldosteronism in the cat: a series of 13 cases. Journal of Feline BALDWIN, K. et al. AAHA Nutritional Assessment Guidelines for Dogs and Cats Special Report. Journal of the American animal hospital association, v. 46, p. 285 – 296, 2010. BANKS, J. W. Sistema Cardiovascular. In: BANKS, J. Histologia Veterinária Aplicada. 2a. ed. Bela Vista: Manole, 1992. p. 352 – 369. BARBERATO, S.; PECOITS-FILHO, R. Artigo de Revisão Alterações Ecocardiográficas em Pacientes com Insuficiência Renal Artigo de Revisão. Arquivos Brasileiros de Cardiologia, v. 94, n. 1, p. 140–146, 2010. BIOMARKERS DEFINITIONS WORKING GROUP. Biomarkers and Surrogate Endpoints: Prederred Definition and Conceptual Framework. Clinical Pharmacology e Therapeutics, v. 69, n. 3, p. 89–95, 2001. BIONDO, A. et al. Immunohistochemistry of Atrial and Brain Natriuretic Peptides in Control Cats and Cats with Hypertrophic Cardiomyopathy. v. 506, p. 501–506, 2003. BLOCK, G. A. et al. Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis. Journal of the American Society of Nephrology, v. 15, n. 8, p. 2208–2218, 2004. BLOCK, G.; PORT, F. K. Calcium Phosphate Metabolism and Cardiovascular Disease in Patients with Chronic Kidney Disease. Seminars in Dialysis, v. 16, n. 2, p. 140–147, 2003. BOND, B. et al. bond Echocardiographic findings in 103 cats with hyperthyroidism. Journal of American Veterinary Medical Association, v. 192, n. 11, p. 1546–1549, 1998. BOON, J. A. Myocardial Diseases. In: BOON, J. A. Veterinary Echocardiography. 2nd. ed. West Sussex: Wiley - Blackwell, 2011. p. 359–410. 79 BOON. Ecocardiografia em Modo-M: uma avaliação quantitaiva. In: BOON, J. A. Ecocardiografia Bidimensional e em Modo-M para o clínico de pequenos animais. 1ed. ed. Wyoming: Roca, 2005. p. 39 – 52. BRANQUINHO, J. et al. DIAGNÓSTICO IMAGIOLÓGICO DE CARDIOMIOPATIA HIPERTRÓFICA. Revista Lusófona de Ciência e Medicina Veterinária, 2010. Disponível em: <http://revistas.ulusofona.pt/index.php/rlcmv/article/view/1614>. Acesso em: 25 jan. 2016 BRIGHT, J. Cardiomiopatia Hipertrofica Felina. In: ABBOTT, J. A. Segredos em Cardiologia de Pequenos Animais. Porto Alegre: Art Med, 2006. p. 321–333. BRISTOW, M. R. Mechanisms of development of heart failure in the hypertensive patient. Cardiology, v. 92 Suppl 1, p. 3–6; discussion 7–9, 20–1, 1999. BROWN, S. et al. Guidelines for the Identification, Evaluation, and Management of Systemic Hypertension in Dogs and Cats. Journal of Veterinary Internal Medicine, v. 21, n. 3, p. 542–558, 2007. CAMACHO, A. A.; MUCHA, C. J. Semiologia do Sitema Circulatório de Cães e Gatos. In: FEITOSA, F. L. F. 1ed. Semiologia Veterinária. 2aed. ed. São Paulo: Roca, 2008. p. 246 – 273. CAMPBELL, F.; KITTLESON, M. The Effect of Hydratation Status on the Echocardiographic Measurements of Normal Cats. Journal of Veterinary Internal Medicine, v. 21, p. 1008–1015, 2007. CARR, A. R.; EGNER, M. Cardiopata em cães e gatos. In: HOSKINS, J. Geriatria e Gerontologia do cão e do Gato. 2a. ed. São Paulo: [s.n.]. p. 141 – 166. CARVALHO, M. V. DE et al. The Influence of Hypertension on Quality of Life. Arquivos Brasileiros de Cardiologia, v. 100, n. 2, p. 164–174, 2013. CHAITMAN, J. et al. Thyroid adenomatous hyperplasia in euthyroid cats. Journal of Veterinary Internal Medicine, v. 13, p. 242, 1999. CHETBOUL, V. et al. Prospective echocardiographic and tissue Doppler screening of a large Sphynx cat population: reference ranges, heart disease prevalence and genetic aspects. Journal of Veterinary Cardiology, v. 14, n. 4, p. 497–509, dez. 2012. CHONG, C. Y. Left Ventricle V. Diastolic function-its principles and Evaluation. In: WEYMAN, A. E. (Ed.). . Principles and Practice of Echocardiography. 2nd. ed. Philadelphia: Lea & Febiger, 1994. p. 721 –780. COSTA, R.; CRUZ, A. Artigo original perfil dos níveis de cálcio iônico, fósforo, produto cálcio-fósforo e paratormônio em pacientes hemodialisados. 2011. CÔTÉ, E. et al. Arterial Thromboembolismo. In: CÔTÉ, E. et al. Feline Cardiology. 1st. ed. West Sussex: Wiley - Blackwell, 2011b. p. 305 – 322. 80 CÔTÉ, E. et al. Cardiac Biomarkers. In: CÔTÉ, E. et al. Feline Cardiology. 1st. ed. West Sussex: Wiley - Blackwell, 2011d. p. 69 – 75. CÔTÉ, E. et al. Congenital Heart Disease. In: CÔTÉ, E. et al. Feline Cardiology. 1st. ed. West Sussex: Wiley - Blackwell, 2011e. p. 85–100. CÔTÉ, E. et al. Congestive Heart Failure. In: CÔTÉ, E. et al. Feline Cardiology. 1st. ed. West Sussex: Wiley - Blackwell, 2011c. p. 257 – 302. CÔTÉ, E. et al. Endocrine Diseases. In: COTE, E. et al. Feline Cardiology. 1st. ed. West Sussex: Wiley - Blackwell, 2011. p. 395–407. CÔTÉ, E. et al. Hypertrophic Cardiomyopathy. In: CÔTÉ, E. et al. Feline Cardiology. 1st. ed. West Sussex: Wiley - Blackwell, 2011a. p. 103 – 175. CÔTÉ, E.; JAEGER, R. Ventricular tachyarrhythmia in 106 cats: associated structural cardiac disorders. Journal of Veterinary Internal Medicine, v. 22, n. 6, p. 1444–6, 2008. DILLMANN, W. H. Cellular Action of Thyroid Hormone on the Heart. Thyroid, v. 12, n. 6, p. 447, 2002. DJAJADININGRAT-LAANEN, S.C., GALAC, S., CAMMELBEECK, S.E., VAN LAAR, K.J.C., BOER, P.; KOOISTRA, H.S. Urinary aldosterone to creatinine ratio in cats before and after suppression with salt or fludrocortisone acetate. Journal of Veterinary Internal Medicine, 22, 1283–1288, 2008. DYCE, K. M.; SACK, W. O.; WENSING, C. J. G. Sistema Cardiovascular. In: DYCE, K. M.; SACK, W. O.; WENSING, C. J. G. Tratado de Anatomia Veternária. 4a. ed. Rio de Janeiro: Elsevier, 2010. p. 215 – 255. EDNEY, A. T.; SMITH, P. Study of obesity in dogs visiting veterinary practices in the United Kingdom. The Veterinary Record, v. 118, n. 14, p. 391 – 396, 1986. FELDMAN, E. C.; NELSON, R. Canine and Feline Endocrinology and Reproduction. 4th. ed. Philadelphia: Saunders, 2014. FELDMAN, E. C.; NELSON, R. W. Proceedings of ESFM Study Day at WSAVA 2000 Acromegaly and hyperadrenocorticism in cats: A clinical perspective. Journal of Feline Medicine and Surgery, v. 2, p. 153–158, 2000. FERASIN, L. et al. Feline idiopathic cardiomyopathy: a retrospective study of 106 cats (1994-2001). Journal of Feline Medicine and Surgery, v. 5, n. 3, p. 151–159, jun. 2003. FERASIN, L. Feline Myocardial Disease 1: Classifications, pathophysiology and clinical presentation. Journal of feline medicine and surgery, v. 11, n. 1, p. 3–13, 2009a. FERASIN, L. Feline Myocardial Disease 2: Diagnosis, prognosis and clinical management. Journal of feline medicine and surgery, v. 11, p. 183–194, 2009b. 81 FINN, E. et al. The relationship between body weight, body condition, and survival in cats with heart failure. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine, v. 24, n. 6, p. 1369–74, 2010. FOX, P. R. Clinical and Pathologic Correlates. Journal of Veterinary Cardiology, v. 5, n. 2, p. 39–45, 2003. FOX, P. R. et al. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats. Journal of Veterinary Cardiology, v. 11 Suppl 1, n. November 2008, p. S51–S61, 2009. FOX, P. R. Feline Cardiomyopathy. WINN Symposium. Anais...New York: 2014Disponível em: <http://www.winnfelinefoundation.org/> FOX, P. R. Feline myocardial diseases. In: FOX, P. R.; SISSON, D. D.; MOISE, S. N. Textbook of Canine and Feline Cardiology Principles and Practice. 2nd. ed. Philadelphia: WB Saunders, 1999. p. 621 –678. FOX, P. R.; BOND, B. R.; PETERSON, M. E. Echocardiographic reference values in healthy cats sedated with ketamine hydrochloride. American Journal of Veterinary Research, v. 46, n. 7, p. 1479–84, 1985. FOX, P. R.; LIU, S.-K.; MARON, B. J. Echocardiographic Assessment of Spontaneously Occurring Feline Hypertrophic Cardiomyopathy : An Animal Model of Human Disease. Circulation, v. 92, n. 9, p. 2645–2651, 1995. FRIES, R.; HEANEY, A. M.; MEURS, K. M. Prevalence of the myosin-binding protein C mutation in Maine Coon cats. Journal of Veterinary Internal Medicine, v. 22, n. 4, p. 893–896, 2008. FUENTES, V. L. ARTERIAL THROMBOEMBOLISM Risks, realities and a rational first-line approach. Journal of feline medicine and surgery, v. 14, p. 459–470, 2014. GOLDEN, A. L.; BRIGHT, J. M. Use of Relaxation half-time as an Index of Ventricular Relaxation in Clinically Normal Cats and Cats with Hypertrophic Cardiomyopathy. American Journal of Veterinary Research, v. 51, n. 9, p. 1352 – 1356, 1990. GOMPF, R. E. The History and Physical Examination. In: TILLEY, L. et al. Manual of Canine and Feline Cardiology. 4th. ed. St. Louis: Elsevier, 2008. p. 2 – 23. GRANSTROM, S. et al. Effect of sample volume size and sampling method on feline longitudinal myocardial velocity profiles from color tissue Doppler imaging. Journal of Veterinary Cardiology, v. 14, n. 4, p. 479–488, 2012. GROSSMAN, W.; MCLAURIN, L. P. Diastolic properties of the left ventricle. Annals Of Internal Medicine, v. 84, n. 3, p. 316–326, 1976. GUGLIELMINI, C. et al. cardiac enlargement in cats with different cardiac disorders. Journal of Feline Medicine and Surgery, v. 16, n. 10, p. 812–825, 2014. 82 GUNDLER, S.; TIDHOLM, A.; HÄGGSTRÖM, J. Prevalence of myocardial hypertrophy in a population of asymptomatic Swedish Maine coon cats. Acta Veterinaria Scandinavica, v. 50, p. 22, 2008. HARRIS, S. P. Hypertrophic Cardiomyopathy in Cardiac Myosin Binding Protein-C Knockout Mice. Circulation Research, v. 90, n. 5, p. 594–601, 2002. HARVEY, A.M.; REFSAL, K.R. Feline hyperaldsoteronism. In MOONEY, C.T. ; PETERSON, M.E., BSAVA Manual of canine and feline endocrinology 4th ed. Gloucester: British p. 204-214, 2012. HSU, A.; KITTLESON, M. D.; PALING, A. Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy. Journal of Veterinary Cardiology, v. 11, n. SUPPL. 1, p. S63–S70, 2009. IRIS. Staging of CKD, 2013. Disponível em: <http://www.iriskidney.com/guidelines/ en/staging/ckd.shtml>. Acesso em: 21 out. 2015. ISMAIL, T. F. et al. Coronary Microvascular Ischemia in Hypertrophic Cardiomyopathy - a Pixel Wise Quantitative Cardiovascular Magnetic Resonance Perfusion Study. Journal of Cardiovascular Magnetic Resonance, v. 16, n. 1, p. 49 – 58, 2014. JEPSON, R. E. Feline systemic hypertension classification and pathogenesis. Journal of Feline Medicine & Surgery, v. 13, n. 1, p. 25–34, 2011. JOHNSON, L. R. Cor Pulmonale and Pulmonary Thromboembolism. In: TILLEY, L. et al. Manual of Canine and Feline Cardiology. 4th. ed. St. Louis: Saunders, 2008. p. 176 – 182. JUNG, W.-I. et al. 31P NMR Spectroscopy Detects Metabolic Abnormalities in Asymptomatic Patients With Hypertrophic Cardiomyopathy. Circulation, v. 97, n. 25, p. 2536–2542, 30 jun. 1998. KATZ, A. M.; KATZ, P. B. Diseases of the heart in dermatomyositis. Sovetskaia Meditsina, v. 31, n. 1, p. 28–33, 1968. KERSHAW, O. et al. Diagnostic value of morphometry in feline hypertrophic cardiomyopathy. Journal of Comparative Pathology, v. 147, n. 1, p. 73–83, 2012. KITTLESON, M. D. et al. Familial hypertrophic cardiomyopathy in Maine coon cats: an animal model of human disease. Circulation, v. 99, p. 3172–3180, 1999. KLEIN, I. Endrocrine Disorders and Cardiovascular Disease. In: LIBBY, P. et al. (Eds.). . Braunwald’s heart disease. 8ed. ed. Philadelphia: Elsevier, 2008. p. 2003–2047. KOGIKA, M.; WAKI, M.; MARTORELLI, C. Doença Renal Crônica. In: JERICÓ, M.; NETO, J.; KOGIA, M. Tratado de Medicina Interna de Cães e Gatos. 1. ed. Rio de Janeiro: Roca, 2015. p. 1394 – 1409. LEVINE, R. A. et al. Papillary Muscle Displacement Causes Systolic Anterior Motion of the Mitral Valve : Experimental Validation and Insights Into the Mechanism of Subaortic Obstruction. Circulation, v. 91, n. 4, p. 1189–1195, 1995. 83 LEVINE, R. A. et al. Unifying concepts of mitral valve function and disease: SAM, prolapse and ischemic mitral regurgitation. Journal of Cardiology, v. 24, n. suppl 38, p. 157 – 169, 1994. LIU, S.; MARON, B.; TILLEY, L. P. Feline Hypertrophic Cardiomyopathy: Gross Anatomic and Quantitative Histologic Features. The American Journal of Pathology, v. 102, n. 1, p. 388 – 395, 1981. MACDONALD, K. Comparison of myocardial contrast enhancement via cardiac magnetic resonance imaging in healthy cats and cats with hypertrophic cardiomyopathy. American Journal of Veterinary Research, v. 66, p. 1891–1894, 2005. MACDONALD, K. In-depth assessment of the diagnosis and treatment of feline hypertrophic cardiomyopathy, with an emphasis on Main Coon cats. Disponível em: <http://www.ivis.org/proceedings/scivac/2008/macdonald3_en.pdf?LA=1>. Acesso em: 18 ago. 2014. MACIEL, B. C. A hipertrofia cardíaca na hipertensão arterial sistêmica: mecanismo compensatório e desencadeante de insuficiência cardíaca. Revista Brasileira de Hipertensão, v. 8, n. 4, p. 409–13, 2001. MARGIOCCO, M. L.; ZINI, E. Short Communications Fixed subaortic stenosis in a cat. Veterinary Record, v. 156, n. 22, p. 16–19, 2005. MARIAN, A. J.; SALEK, L.; LUTUCUTA, S. Molecular genetics and pathogenesis of hypertrophic cardiomyopathy. Minerva Medica, v. 92, n. 6, p. 435–451, 2001. MARINO, C. L. et al. Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies. Journal of Feline Medicine and Surgery, v. 16, n. 6, p. 465–472, 2014. MARON, B. et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the European S. Journal of the American College of Cardiology, v. 42, n. 9, p. 1687–1713, 2003. MARON, B. J. et al. Hypertrophic Cardiomyopathy. The New England Journal of Medicine, v. 316, n. 13, p. 844 – 852, 1987. MARON, B. J. et al. Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic Cardiomyopathy. Circulation, v. 109, p. 984–989, 2004. MARON, B.; ROBERTS, W.; EPSTEIN, S. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation, v. 65, n. 7, p. 1388–1394. MARTEL, E. et al. Comparison of high-definition oscillometry -- a non-invasive technology for arterial blood pressure measurement -- with a direct invasive method using radio-telemetry 84 in awake healthy cats. Journal of Feline Medicine and Surgery, v. 15, n. 12, p. 1104–1113, 2013. MARTINS, A. J. S. Estudo De Incidência De Hipertiroidismo Felino [s.l.] Universidade Lusófona De Humanidades E Tecnologias, 2012. MEURS, K. M. et al. A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy. Human Molecular Genetics, v. 14, n. 23, p. 3587–3593, 2005. MEURS, K. M. et al. A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy. Genomics, v. 90, n. 2, p. 261–264, 2007. MEURS, K. M. Triagem genética para cardiomiopatia hipertrófica familiar. In: AUGUST, J. R. Medicina Interna de felinos. 6a. ed. Rio de Janeiro: Elsevier, 2011a. p. 408 – 411. MOISE, N. S. et al. Echocardiography, electrocardiography, and radiography of cats with dilatation cardiomyopathy, hypertrophic cardiomyopathy, and hyperthyroidism. American Journal of Veterinary Research, v. 47, n. 7, p. 1476–86, 1986. MOONEY, C. Hyperthyroidism. In: ETTINGER, S.; FELDMAN, E. Textbook of veterinary internal medicine. 6th. ed. St Louis: Elsevier, 2005. p. 471 – 475. NAGUEH, S. F. et al. Recomemmendations for evaluation of left ventricular diastolic function by echocardiography. Journal of the American Society of Echocardiography, v. 22, n. 2, p. 107–133, 2009. NEVES, C. L. et al. O Hiperparatireoidismo Secundário e a Doença Cardiovascular na Doença Renal Crônica. Jornal Brasileiro de Nefrologia, v. 30, p. 18–22, 2008. NICOL, R. L.; FREY, N.; OLSON, E. N. FROM THE SARCOMERE TO THE NUCLEUS: Role of Genetics and Signaling in Structural Heart Disease. Annual Review of Genomics and Human Genetics, v. 1, n. 1, p. 179 – 223, 2000. NIESSEN, S. J. M. et al. Feline Acromegaly: An Underdiagnosed Endocrinopathy? Journal of Veterinary Internal Medicine, v. 21, p. 899–905, 2007. NOBREGA, S. C. C. Cardiomiopatia Hipertrófica Felina: A propósito de 5 casos clínicos. 2011. [s.l.] Universidade Técnica de Lisboa, 2001. NORSWORTHY, G. Relationship between semi-quantitative thyroid palpation and total thyroxine concentration in cats with and without hyperthyroidism. Journal of Feline Medicine & Surgery, v. 4, n. 3, p. 139–143, 1 set. 2002. OMS. Guidelines for dog population management. Genova: 1990 OPIE, L. H. Overload Hypertrophy and Its Molecular Biology. In: Heart Physiology From Cell to Circulation. 4th. ed. Philadelphia: Lippincott Willians & Wilkins, 2004. p. 402 – 427. 85 PAIGE, C. F. et al. Prevalence of cardiomyopathy in apparently healthy cats. Journal of the American Veterinary Medical Association, v. 234, n. 11, p. 1398–1403, 2009. PIMENTEL-GOMES, F. Curso de estatística experimental. 14ed. ed. Piracicaba: Nobel, 2000. PITTARI, J. et al. American Association of feline Practioners Senior Care Guidelines. Journal of Feline Medicine and Surgery, v. 11, p. 763–778, 2009. POUCHELON, J. L. et al. Cardiovascular-renal axis disorders in the domestic dog and cat: A veterinary consensus statement. Journal of Small Animal Practice, v. 56, n. 9, p. 537–552, 2015. PROSEK, R. et al. Measurements of Plasma Endothelin Immunoreactivity in Healthy Cats and Cats with Cardiomyopathy. v. 18, n. 6, p. 826–830, 2004. REIS, L.; JORGETTI, V. Distúrbio do cálcio e fósforo vasoativos. In: ZATZ, R. (Ed.). . Série fisiopatologia clínica: Fisiologia renal. São Paulo: Atheneu, 2000. p. 245 – 260. RISHNIW, M.; PION, P. D. Is treatment of feline hypertrophic cardiomyopathy based in science or faith? A survey of cardiologists and a literature search. Journal of Feline Medicine and Surgery, v. 13, n. 7, p. 487–497, jul. 2011. RONCO, C. et al. Cardiorenal Syndrome. Journal of the American College of Cardiology, v. 52, n. 19, p. 1527–1539, 2008. RUSH, J. et al. Population and survival characteristics of cats with hyertrophic cardiomyopathy: 260 cases (1990 – 1999). Journal of the American Veterinary Association, v. 220, n. 4, p. 202–207, 2002. SAMPAIO, I. Estatística aplicada a experimentação animal. 2ed. ed. Belo Horizonte: [s.n.]. SAMPEDRANO, C. C. et al. Systolic and Diastolic Myocardial Dysfunction in Cats with Hypertrophic Cardiomyopathy or Systemic Hypertension. v. 20, p. 1106–1115, 2006. SCHOBER, K. E.; MAERZ, I.; LUDEWIG, E. Diagnostic accuracy of eletrocardiography and thoracic radiography in the assessment of left atrial size in cats: comparison with transthoracic 2-dimensional echocardiography. Journal of Veterinarian Internal Medicine, v. 21, p. 709–718, 2007. SCHULMAN, R.L.Feline primary hyperaldosteronism. Veterinary Clinics of North America: Small Animal Practice, 40(2), p.353-359, 2010 SCHWARTZ, D. Cardiomiopatia hipertrófica. In: M, J. H. Coletâneas em Medicina e Cirurgia Felina. 1ed. ed. Rio de Janeiro: L.F Livros, 2003. p. 25 – 41. SHERRID, M. et al. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. Journal of the American College of Cardiology, v. 36, n. 4, p. 1344 – 54, 2000. 86 SHERRID, M. Pathophysiology and treatment of hypertrophic cardiomyopathy. Progress in Cardiovascular Disease, v. 49, n. 2, p. 123 –151, 2006a. SHERRID, M. V; PEARLE, G.; GUNSBURG, D. Z. Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy. Journal of the American Heart Association, v. 97, p. 41–47, 1998. SILVA, C. E. V et al. Cardiomiopatia Hipertrófica Em Um Gato Doméstico (Felis catus) Associada a Infarto Miocárdico Agudo. Ciência Animal Brasileira, v. 10, n. 01, p. 335–341, 2009. SISSON, D. D. Neuroendocrine evaluation of cardiac disease. The Veterinary Clinics Of North America: Small Animal Practice, v. 34, n. 5, p. 1105–1126, 2004. SMITH, A. Arterial thrombo-embolism in cats: acute crises in 127 cases (1992 – 2001) and long-term management with low dose aspirin in 24 cases. Journal of Veterinarian Internal Medicine, v. 17, p. 73–83, 2003. SPALLA, I. et al. Survival in cats with primary and secondary cardiomyopathies. Journal of Feline Medicine and Surgery, p. 1098612X15588797–, 9. 2015. STEPIEN, R. L. Feline systemic hypertension diagnosis and management. Journal of Feline Medicine and Surgery, v. 13, n. 1, p. 35–43, 2011. STRICKLAND. Pathophysiology and Therapy of Heart Failure. In: TILLEY, L. P. et al. Manual of Canine and Feline Cardiology. 4th. ed. St. Louis: Elsevier, 2008. p. 288 – 314. SWYNGHEDAUW, B. Molecular mechanisms of myocardial remodeling. Physiological Reviews, v. 79, n. 1, p. 215–62, 1999. TARDIFF, J. C. Sarcomeric Proteins and Familial Hypertrophic Cardiomyopathy: Linking Mutations in Structural Proteins to Complex Cardiovascular Phenotypes. Heart Failure Reviews, v. 10, n. 3, p. 237 – 248, 2005. TILLEY, J. Acromegalia – gatos. In: TILLEY, L.; SMITH J.R., F. W. Consulta veterinária em 5 minutos. Espécies canina e felina. Sao paulo: Manole, 2008. p. 26–27. TILLEY, L. et al. Primary myocardial disease in the cat. A model for human cardiomyopathy. The American Journal of Pathology, v. 86, n. 3, p. 493–522, 1977. TILLEY, L. P. Analysis of common feline cardaic arrhythmias. In: TILLEY, L. P. Essential of Canine and feline Electrocardiography. 3rd. ed. New York: Essential of Canine and feline Electrocardiography, 1992. p. 208–251. WAGNER, T. et al. Comparison of auscultatory and echocardiographic findings in healthy adult cats. Journal of Veterinary Cardiology, v. 12, n. 3, p. 171–82, 2010. WARE, W. E. Myocardial disease of the cat. In: WARE, W. (Ed.). . Cardiovascular Disease in Small Animal Medicine. 2nd. ed. London: Manson Publishing, 2011. p. 300–310. 87 WESS, G. et al. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats. Veterinary Clinical Pathology, v. 40, n. 2, p. 237–244, 2011. WILLIAMS, T. L.; ELLIOTT, J.; SYME, H. M. Renin-angiotensin-aldosterone system activity in hyperthyroid cats with and without concurrent hypertension. Journal of Veterinary Internal Medicine, v. 27, n. 3, p. 522–529, 2013. WINTER, M. D. et al. Associations between 'valentine' heart shape, atrial enlargement and Cardiomyopathy in cats. Journal of Feline Medicine and Surgery, v. 17, n. 6, p. 1–6, 2014. WU, H. et al. Cardiac troponin I in cats with hypertrophic cardiomyopathy. Journal of Feline Medicine and Surgery, v. 117, n. 6, p. 209–216, 2003. WYNNE, J. W.; BRAUNWALD, E. The cardiomyopathies and myocarditis. In: BRAUNWALD, E. A Textbook of Cardiovascular Medicine. 9th. ed. Philadelphia: 2014. p. 1751–1806.por
dc.subject.cnpqCiências Agráriaspor
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/5338/2016%20-%20Bruno%20Ricardo%20Soares%20A.%20da%20Silva.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/20058/2016%20-%20Bruno%20Ricardo%20Soares%20A.%20da%20Silva.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/26329/2016%20-%20Bruno%20Ricardo%20Soares%20A.%20da%20Silva.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/32748/2016%20-%20Bruno%20Ricardo%20Soares%20A.%20da%20Silva.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/39182/2016%20-%20Bruno%20Ricardo%20Soares%20A.%20da%20Silva.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/45570/2016%20-%20Bruno%20Ricardo%20Soares%20A.%20da%20Silva.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/51898/2016%20-%20Bruno%20Ricardo%20Soares%20A.%20da%20Silva.pdf.jpg*
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/58398/2016%20-%20Bruno%20Ricardo%20Soares%20A.%20da%20Silva.pdf.jpg*
dc.originais.urihttps://tede.ufrrj.br/jspui/handle/jspui/1480
dc.originais.provenanceSubmitted by Sandra Pereira (srpereira@ufrrj.br) on 2017-03-24T11:59:07Z No. of bitstreams: 1 2016 - Bruno Ricardo Soares A. da Silva.pdf: 2937766 bytes, checksum: 9d74f19c8b592d9a097f535ef56dd464 (MD5)eng
dc.originais.provenanceMade available in DSpace on 2017-03-24T11:59:07Z (GMT). No. of bitstreams: 1 2016 - Bruno Ricardo Soares A. da Silva.pdf: 2937766 bytes, checksum: 9d74f19c8b592d9a097f535ef56dd464 (MD5) Previous issue date: 2016-02-29eng
Appears in Collections:Mestrado em Medicina Veterinária (Patologia e Ciências Clínicas)

Se for cadastrado no RIMA, poderá receber informações por email.
Se ainda não tem uma conta, cadastre-se aqui!

Files in This Item:
File Description SizeFormat 
2016 - Bruno Ricardo Soares A. da Silva.pdf2016 - Bruno Ricardo Soares A. da Silva2.87 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.